我院吗替麦考酚酯超说明书用药评价Evaluation of the off-lable use of mycophenolate mofetil in our hospital
薛静;高旻;张文瑞;郑卓玲;覃利;黎小妍;
摘要(Abstract)：
目的通过循证医学方法评价和规范吗替麦考酚酯的超说明用药。方法回顾性抽取2019年吗替麦考酚酯住院医嘱423份,对超说明书用药情况进行统计分析,并以Micromedex Thomson分级标准、国内外权威指南、专家共识、诊疗规范或高级别文献研究为依据,判断超说明书用药的合理性。结果吗替麦考酚酯超说明书用药医嘱281份,占含吗替麦考酚酯总医嘱的66.4%,均为超适应证用药。发生率排名前3的科室依次为肾内科、风湿免疫科和神经科。超适应证医嘱中临床诊断以肾病综合征、系统性红斑狼疮和视神经脊髓炎多见。结论吗替麦考酚酯超适应证用药有国内外诊疗指南推荐或高级别文献支持,患者用药有指征,用药合理。
关键词(KeyWords)： 吗替麦考酚酯;超说明书;循证医学;用药评价
基金项目(Foundation):
作者(Author): 薛静;高旻;张文瑞;郑卓玲;覃利;黎小妍;
Email:
DOI: 10.19577/j.1007-4406.2021.01.011
参考文献(References)：
- [1]张镭,谭玲,陆进.超说明书用药专家共识[J].药物不良反应杂志,2015,17(2):101.
- [2]李玉堂,杨昌云,王佳坤,等.超说明书用药原因分析及对策[J].医药导报,2012,31(3):400.
- [3]吗替麦考酚酯在自身免疫病治疗中应用的风湿病专家共识小组.吗替麦考酚酯在自身免疫病治疗中应用的风湿病专家共识[J].中华风湿病学杂志,2019,23(7):436.
- [4]中华医学会.临床诊疗指南:肾脏病学分册[M].北京:人民卫生出版社,2011:6-7.
- [5]中华医学会儿科学会分会肾脏病学组.儿童常见肾脏疾病诊治循征指南(一)[J].中华儿科杂志,2009,7(3):169.
- [6]中国成人肾病综合征免疫抑制治疗专家组.中国成人肾病综合征免疫抑制治疗专家共识[J].中华肾脏病杂志,2014,30(6):467.
- [7]吗替麦考酚酯在肾内科应用专家协作组.吗替麦考酚酯在肾内科应用的指导意见[J].中华肾脏病杂志,2004,20(5):385.
- [8]HAHN B H,McMAHON M A,WILKINSON A,et al.American College of Rheumatology guidelines for screening,treatment,and management of lupus nephritis[J].Arthritis Care Res,2012,64(6):797.
- [9]FANOURIAKIS A,KOSTOPOULOU M,ALUNNO A,et al.2019update of the EULAR recommendations for the management of systemic lupus erythematosus[J].Ann Rheum Dis,2019,78(6):736.
- [10]广东省药学会风湿免疫用药专家委员会.风湿免疫疾病超药品说明书用药专家共识(之二):系统性红斑狼疮[J].中国现代应用药学,2017,34(3):444.
- [11]JACOB A,MATIELLO M,WEINSHENKER B G,et al.Treatment of neuromyelitis optica with mycophenolate mofetil:retrospective analysis of 24 patients[J].Arch Neurol,2009,66(9):1128.
- [12]HUH S Y,KIM S H,HYUN J W,et al.Mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorder[J].JAMA Neurol,2014,71(11):1372.
- [13]TREBST C,JARIUS S,BERTHELE A,et al.Update on the diagnosis and treatment of neuromyelitis optica:recommendations of the Neuromyelitis Optica Study Group (NEMOS)[J].JNeurol,2014,261(1):1.
- [14]MEALY M A,WINGERCHUK D M,PALACE J,et al.Comparison of relapse and treatment failure rates among patients with neuromyelitis optica:multicenter study of treatment efficacy[J].JAMA Neurol,2014,71(3):324.
- [15]中国免疫学会神经免疫学分会,中华医学会神经病学分会神经免疫学组,中国医师协会神经内科分会神经免疫专业委员会.中国视神经脊髓炎谱系疾病诊断与治疗指南[J].中国神经免疫学和神经病学杂志,2016,23(3):155.
- [16]TAYLOR A,NEAVE L,SOLANKI S,et al.Mycophenolate mofetil therapy for severe immune thrombocytopenia[J].Br J Haematol,2015,171(4):625.
- [17]ARNOLD D M,NAZI I,SANTOS A,et al.Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura[J].Blood,2010,115(1):29.
- [18]STRATTON R J,WILSON H,BLACK C M.Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma[J].Rheumatology(Oxford),2001,40(1):84.
- [19]NIHTYANOVA S I,BROUGH G M,BLACK C M,et al.Mycophenolate mofetil in diffuse cutaneous systemic sclerosis:a retrospective analysis[J].Rheumatology (Oxford),2007,46(3):442.
- [20]LE E N,WIGLEY F M,SHAH A A,et al.Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis[J].Ann Rheum Dis,2011,70(6):1104.
- [21]HERRICK A L,PAN X,PEYTRIGNET S,et al.Treatment outcome in early diffuse cutaneous systemic sclerosis:the European Scleroderma Observational Study(ESOS)[J].Ann Rheum Dis,2017,76(7):1207.
- [22]TASHKIN D P,ROTH M D,CLEMENTS P J,et al.Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease(SLS II):a randomised controlled,double-blind,parallel group trial[J].Lancet Respir Med,2016,4(9):708.
- [23]中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识(2015)[J].中华传染病杂志,2016,34(4):193.
- [24]王绮夏,蒋翔,连敏,等.2015年欧洲肝病学会临床实践指南:自身免疫性肝炎[J].临床肝胆病杂志,2015,31(12):2000.
- [25]RICHARDSON P D,JAMES P D,RYDER S D.Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine[J].J Hepatol,2000,33(3):371.
- [26]INDUCTIVO-YU I,ADAMS A,GISH R G,et al.Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy[J].Clin Gastroenterol Hepatol,2007,5(7):799.
- [27]中国医师协会皮肤科医师分会自身免疫性疾病亚专业委员.大疱性类天疱疮诊断和治疗的专家建议[J].中华皮肤科杂志,2016,49(6):384.
- [28]MARTIN L K,WERTH V P,VILLANEUVA E V,e t a l.Asystematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus[J].J Am Acad Dermatol,2011,64(5):903.
- [29]CHAMS-DAVATCHI C,ESMAILI N,DANESHPAZHOOH M,et al.Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris[J].J Am Acad Dermatol,2007,57(4):622.